Stockscreener 앱 받기
1.02
7.08%
0.0675
시간 외 거래:
1.96
0.94
+92.16%
Neuroone Medical Technologies Corp 주식(NMTC)의 최신 뉴스
NeuroOne Targets May 2025 FDA Submission For OneRF Trigeminal Nerve Ablation System - Nasdaq
NeuroOne accelerates FDA submission timeline for nerve ablation tech - Mass Device
NeuroOne speeds up FDA submission for nerve ablation system - Investing.com
NeuroOne Speeds Up FDA Timeline: Revolutionary Facial Pain Treatment Could Hit Market Earlier Than Expected - StockTitan
NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference - Barchart
Can NeuroOne's Upcoming Investor Presentation Signal New Growth in Neurological Tech? - StockTitan
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q1 2025 Earnings Call Transcript - MSN
Earnings call transcript: NeuroOne Medical sees Q1 2025 revenue surge - MSN
NeuroOne Medical Technologies Corp (NMTC) Q1 2025 Earnings Call - GuruFocus.com
NeuroOne Medical Technologies Corp (NMTC) Q1 2025 Earnings Call Highlights: Record Revenue and ... - Yahoo Finance
Earnings call transcript: NeuroOne Medical sees Q1 2025 revenue surge By Investing.com - Investing.com Canada
NeuroOne Medical Technologies Corp Reports Q1 FY2025 Earnings: E - GuruFocus.com
NEUROONE MEDICAL TECHNOLOGIES Corp SEC 10-Q Report - TradingView
NeuroOne Reports First Quarter Fiscal Year 2025 Financial Results - TradingView
Q1 Earnings Breakthrough: NeuroOne Hits Record $6.3M Revenue as Product Sales Triple - StockTitan
NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. - EIN News
NeuroOne Medical Earnings Alert: Key Q1 2025 Results and Strategic Updates Coming February 12 - StockTitan
NeuroOne regains Nasdaq compliance with share price By Investing.com - Investing.com South Africa
NeuroOne regains Nasdaq compliance with share price - Investing.com
Breakthrough Brain Tech Company Posts Massive Revenue Jump After Crucial Nasdaq Win - StockTitan
Contrasting NeuroOne Medical Technologies (NASDAQ:NMTC) and Inari Medical (NASDAQ:NARI) - Defense World
NeuroOne CEO shares company strategy in letter to shareholders - Investing.com
NeuroOne faces Nasdaq delisting over share price issue By Investing.com - Investing.com Australia
NeuroOne Medical Technologies Faces Delisting from Nasdaq Due to Non-Compliance - Defense World
NeuroOne faces Nasdaq delisting over share price issue - Investing.com India
NeuroOne Reports Record Revenue Boost in Q1 2025 - Yahoo Finance
NeuroOne Medical Revenue Surges 520% to Record $6.2M, Boosted by Zimmer Biomet Deal - StockTitan
NeuroOne Medical Projects 190% Revenue Growth, Expands Zimmer Biomet Partnership - StockTitan
NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11: 00 a.m. EST - Marketscreener.com
NeuroOne Medical Projects 190% Revenue Growth, Sets Investor Webinar to Showcase Expansion - StockTitan
NeuroOne Medical Technologies Reports Increased Product Revenue and Strategic Partnerships in 2024 - Defense World
NeuroOne Medical Technologies Corp (NMTC) Q4 2024 Earnings Call Highlights: Strategic ... - Yahoo Finance
Earnings call transcript: NeuroOne Q4 2024 sees stock surge on innovation - Investing.com Australia
Earnings call transcript: NeuroOne Q4 2024 sees stock surge on innovation By Investing.com - Investing.com South Africa
NeuroOne Medical Technologies Corp Reports Q4 Net Loss of $3.3 M - GuruFocus.com
NeuroOne Medical Projects 190% Revenue Growth for 2025 After Record-Breaking Year - StockTitan
Neuroone stock hits 52-week low at $0.56 amid market challenges - Investing.com
NeuroOne Medical Technologies Sets Q4 2024 Earnings Release Date - StockTitan
Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing - The Globe and Mail
Nashville InnoNeuroOne CEO Dave Rosa talks uplisting on Nasdaq, year ahead - The Business Journals
Neuroone stock hits 52-week low at $0.59 amid market challenges - Investing.com
AWM Investment Company, Inc. Increases Stake in NeuroOne Medical Technologies Corp - GuruFocus.com
NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event - Yahoo Finance
NeuroOne ends loan agreement with Growth Opportunity Funding - Investing.com
Zimmer Biomet to Present at Jefferies London Healthcare Conference - Marketscreener.com
NeuroOne agree $3m partnership with Zimmer Biomet - Yahoo! Voices
NeuroOne expands agreement with Zimmer Biomet for commercialisation of OneRF ablation system - NeuroNews International
Zimmer licenses NeuroOne brain ablation system - Yahoo Finance
NeuroOne Expands OneRF Distribution Deal with Zimmer Biomet - MPO-mag
NeuroOne expands distribution with Zimmer Biomet - Investing.com
NeuroOne Medical Technologies adjusts executive severance terms - Investing.com
NeuroOne touts breakthrough case with neuroablation system - Mass Device
Zimmer Biomet to Present at the Wells Fargo 2024 and Morgan Stanley Annual Global Healthcare Conferences - Marketscreener.com
NeuroOne Pockets Over $5M, Inks OneRF Distribution Deal - MPO-mag
3.40%
0.89%
자본화:
|
볼륨(24시간):